Microcap Ledger SenesTech, Inc. $SNES
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Capital Market
- Sector
- Agricultural Chemicals
- Headquarters
- Phoenix, AZ
- Fiscal year end
- December 31
- Shares outstanding
- 5,423,542 [10-Q 2026-08-06]
What the company doesAI summary of filing
SenesTech develops and commercializes fertility control products for managing rat and mouse populations. The company's primary revenue-generating product is Evolve, a soft bait containing cottonseed oil that was launched in January 2024 and reduces fertility in both male and female rodents; Evolve Rat is authorized for sale in 48 states and territories, and Evolve Mouse, introduced in May 2024, is authorized in 37 states and territories. The company also markets ContraPest, a liquid bait containing VCD and triptolide that received EPA registration in August 2016 and is registered in all 50 states and major U.S. territories. SenesTech generates revenue through sales of these fertility control products to pest management providers, agricultural operators, industrial facilities, and retail channels, positioning them as alternatives to traditional lethal rodenticides and as tools for integrated pest management programs. [10-K 2026-03-13]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $1.26M | −$3.90M | −$3.64M | $5.08M | [10-Q 2026-08-06] |
| FY ended Dec 2025 | $2.22M | −$6.38M | −$5.75M | $7.58M | [10-K 2026-03-13] |
| FY ended Dec 2024 | $1.86M | −$6.18M | −$6.03M | $1.31M | [10-K 2026-03-13] |
- Quarterly cash burn
- −$1.82M
- Cash runway Estimate
- ~8.4 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-08 | 1,033,644 | [10-Q 2024-11-12] |
| 2025-03-11 | 1,746,930 | [10-K 2025-03-13] |
| 2025-05-05 | 1,775,930 | [10-Q 2025-05-08] |
| 2025-08-05 | 5,223,015 | [10-Q 2025-08-08] |
| 2025-11-07 | 5,223,015 | [10-Q 2025-11-10] |
| 2026-03-11 | 5,303,426 | [10-K 2026-03-13] |
| 2026-05-11 | 5,303,426 | [10-Q 2026-05-13] |
| 2026-08-04 | 5,423,542 | [10-Q 2026-08-06] |
- Shelf registration
- S-3 filed 2025-08-15; declared effective 2025-08-22 [S-3 2025-08-15]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-09-28 | Edell Michael | buy | 2,000 | $0.64 | [4 2026-09-29] |
| 2026-09-14 | Edell Michael | buy | 1,000 | $0.84 | [4 2026-09-15] |
| 2026-09-09 | Edell Michael | buy | 1,000 | $0.89 | [4 2026-09-10] |
| 2026-09-09 | Edell Michael | buy | 1,000 | $0.85 | [4 2026-09-10] |
| 2026-08-14 | Edell Michael | buy | 1,000 | $1.21 | [4 2026-08-17] |
| 2026-08-07 | Glenbrook Capital Management | buy | 6,490 | $1.30 | [4 2026-08-10] |
| 2026-08-06 | Glenbrook Capital Management | buy | 15,000 | $1.30 | [4 2026-08-10] |
| 2026-07-20 | Glenbrook Capital Management | buy | 35,000 | $1.47 | [4 2026-07-22] |
| 2026-07-07 | Edell Michael | buy | 1,000 | $1.43 | [4 2026-07-08] |
| 2026-06-30 | Glenbrook Capital Management | buy | 35,000 | $1.51 | [4 2026-07-02] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-08-05 | 8-K | Results of operations |
| 2026-08-03 | 8-K | Results of operations |
| 2026-07-23 | 13D | Beneficial ownership report (5%+ holder) |
| 2026-06-10 | 8-K | Shareholder vote results |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-05-12 | 8-K | Results of operations |
| 2026-05-07 | 8-K | Director or officer change |
| 2026-04-29 | DEF 14A | Proxy statement |
| 2026-03-18 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-03-13 | 10-K | Annual report |
| 2026-03-12 | 8-K | Results of operations |
Alerts for $SNES
Email me when SenesTech, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.